vs
Side-by-side financial comparison of MetroCity Bankshares, Inc. (MCBS) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $43.7M, roughly 1.7× MetroCity Bankshares, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 23.6%). MetroCity Bankshares, Inc. produced more free cash flow last quarter ($37.0M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 15.7%).
Metro City Bank is a Korean-American bank based in Doraville, Georgia and offers personal and commercial banking services. It is the largest Korean-American bank to not be based out of Los Angeles, California. It currently operates a total of 19 branches in Texas, New York, New Jersey, Virginia, Georgia, Alabama, and Florida.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
MCBS vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.7M | $75.5M |
| Net Profit | $18.1M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 52.8% | 22.7% |
| Net Margin | 50.5% | — |
| Revenue YoY | 23.6% | 27.7% |
| Net Profit YoY | 11.7% | — |
| EPS (diluted) | $0.69 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.7M | $75.5M | ||
| Q3 25 | $38.0M | $54.5M | ||
| Q2 25 | $37.9M | $52.4M | ||
| Q1 25 | $36.0M | $46.0M | ||
| Q4 24 | $35.4M | $59.1M | ||
| Q3 24 | $36.9M | $80.5M | ||
| Q2 24 | $36.3M | $47.1M | ||
| Q1 24 | $32.7M | $43.8M |
| Q4 25 | $18.1M | — | ||
| Q3 25 | $17.3M | $8.8M | ||
| Q2 25 | $16.8M | $5.9M | ||
| Q1 25 | $16.3M | $3.0M | ||
| Q4 24 | $16.2M | — | ||
| Q3 24 | $16.7M | $20.3M | ||
| Q2 24 | $16.9M | $-4.5M | ||
| Q1 24 | $14.6M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 52.8% | 22.7% | ||
| Q3 25 | 62.8% | 17.6% | ||
| Q2 25 | 62.4% | 12.7% | ||
| Q1 25 | 61.3% | 8.7% | ||
| Q4 24 | 58.9% | 22.6% | ||
| Q3 24 | 61.4% | 27.4% | ||
| Q2 24 | 64.4% | -4.6% | ||
| Q1 24 | 62.6% | -5.3% |
| Q4 25 | 50.5% | — | ||
| Q3 25 | 45.5% | 16.2% | ||
| Q2 25 | 44.4% | 11.2% | ||
| Q1 25 | 45.3% | 6.5% | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 45.3% | 25.2% | ||
| Q2 24 | 46.7% | -9.6% | ||
| Q1 24 | 44.8% | -11.0% |
| Q4 25 | $0.69 | $0.26 | ||
| Q3 25 | $0.67 | $0.17 | ||
| Q2 25 | $0.65 | $0.12 | ||
| Q1 25 | $0.63 | $0.06 | ||
| Q4 24 | $0.64 | $0.40 | ||
| Q3 24 | $0.65 | $0.41 | ||
| Q2 24 | $0.66 | $-0.09 | ||
| Q1 24 | $0.57 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $383.7M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $544.2M | $130.3M |
| Total Assets | $4.8B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $383.7M | $97.5M | ||
| Q3 25 | $227.2M | $94.4M | ||
| Q2 25 | $286.0M | $96.0M | ||
| Q1 25 | $285.1M | $93.2M | ||
| Q4 24 | $249.9M | $101.0M | ||
| Q3 24 | $291.2M | $96.7M | ||
| Q2 24 | $327.9M | $96.8M | ||
| Q1 24 | $258.8M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $544.2M | $130.3M | ||
| Q3 25 | $445.9M | $115.3M | ||
| Q2 25 | $436.1M | $104.7M | ||
| Q1 25 | $428.0M | $97.1M | ||
| Q4 24 | $421.4M | $92.1M | ||
| Q3 24 | $407.2M | $71.1M | ||
| Q2 24 | $407.2M | $48.5M | ||
| Q1 24 | $396.6M | $51.0M |
| Q4 25 | $4.8B | $216.3M | ||
| Q3 25 | $3.6B | $202.9M | ||
| Q2 25 | $3.6B | $194.9M | ||
| Q1 25 | $3.7B | $196.2M | ||
| Q4 24 | $3.6B | $213.3M | ||
| Q3 24 | $3.6B | $220.7M | ||
| Q2 24 | $3.6B | $205.0M | ||
| Q1 24 | $3.6B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.7M | $14.4M |
| Free Cash FlowOCF − Capex | $37.0M | $14.4M |
| FCF MarginFCF / Revenue | 84.7% | 19.1% |
| Capex IntensityCapex / Revenue | 1.5% | 0.0% |
| Cash ConversionOCF / Net Profit | 2.08× | — |
| TTM Free Cash FlowTrailing 4 quarters | $79.4M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.7M | $14.4M | ||
| Q3 25 | $16.5M | $9.7M | ||
| Q2 25 | $14.5M | $14.1M | ||
| Q1 25 | $11.9M | $3.6M | ||
| Q4 24 | $63.5M | $15.6M | ||
| Q3 24 | $-11.5M | $11.0M | ||
| Q2 24 | $19.4M | $1.0M | ||
| Q1 24 | $36.4M | $11.2M |
| Q4 25 | $37.0M | $14.4M | ||
| Q3 25 | $16.2M | $9.7M | ||
| Q2 25 | $14.3M | $14.1M | ||
| Q1 25 | $11.8M | $3.6M | ||
| Q4 24 | $62.2M | $15.6M | ||
| Q3 24 | $-11.8M | $11.0M | ||
| Q2 24 | $19.0M | $1.0M | ||
| Q1 24 | $36.1M | — |
| Q4 25 | 84.7% | 19.1% | ||
| Q3 25 | 42.7% | 17.7% | ||
| Q2 25 | 37.8% | 26.8% | ||
| Q1 25 | 32.9% | 7.7% | ||
| Q4 24 | 175.8% | 26.4% | ||
| Q3 24 | -31.9% | 13.7% | ||
| Q2 24 | 52.4% | 2.1% | ||
| Q1 24 | 110.6% | — |
| Q4 25 | 1.5% | 0.0% | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 3.6% | 0.0% | ||
| Q3 24 | 0.8% | 0.0% | ||
| Q2 24 | 1.0% | 0.0% | ||
| Q1 24 | 0.7% | 0.0% |
| Q4 25 | 2.08× | — | ||
| Q3 25 | 0.95× | 1.10× | ||
| Q2 25 | 0.86× | 2.41× | ||
| Q1 25 | 0.73× | 1.21× | ||
| Q4 24 | 3.91× | — | ||
| Q3 24 | -0.69× | 0.54× | ||
| Q2 24 | 1.14× | — | ||
| Q1 24 | 2.49× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
